OR WAIT null SECS
August 21, 2018
Experts from the Partnership for Research on Ebola VACcination report on progress and uncertainties regarding a safe and effective Ebola vaccine.
August 20, 2018
The National Institute of Allergy and Infectious Diseases began a first-in-human trial of an experimental live, attenuated Zika virus vaccine.
August 17, 2018
The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.
August 16, 2018
The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.
August 09, 2018
Ebola vaccinations by the World Health Organization began in North Kivu, Democratic Republic of the Congo, one week after the country’s latest outbreak.
June 22, 2018
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
June 14, 2018
Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.
May 30, 2018
World Health Organization’s Ebola ring vaccination uses Merck & Co.’s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.
May 09, 2018
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 02, 2018
Public health authorities and the biomedical research community are seeking new strategies to address global health threats.